Viewing Study NCT04626635


Ignite Creation Date: 2025-12-24 @ 10:09 PM
Ignite Modification Date: 2025-12-30 @ 8:27 AM
Study NCT ID: NCT04626635
Status: RECRUITING
Last Update Posted: 2025-12-03
First Post: 2020-11-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Trial to Find Out How Safe REGN7075 is and How Well it Works in Combination With Cemiplimab for Adult Participants With Advanced Cancers
Sponsor: Regeneron Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module